1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Lonza Group AG
  6. Company
    LONN   CH0013841017

LONZA GROUP AG

(LONN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Lonza Group AG
Lonza Group is one of the world leaders of the development, production and marketing of chemical products. Net sales break down by family of products and services as follows:

- bio-pharmaceuticals and nutritional ingredients (70.4%): exclusive syntheses, microbiological fermentation products , mammalian cell cultures, nutritional ingredients, etc. In addition, the group offers dosage solutions for biopharmaceuticals, drugs and nutrition products;

- fine organic and performance chemical products (28.6%): for food products, hygiene products, beauty products and wood care products, etc.;

- other (1%).

Net sales break down geographically as follows: Switzerland (9.7%), Europe (28.3%), the United States (42.3%), Americas (3.8%), Asia (14.2%), Australia and New Zealand (1.3%), Africa (0.3%) and other (0.1%).

Number of employees : 16 218 people.
Sales per Business
20202021Delta
Biologics--2 699.0049.9%-
Capsules & Health Ingredients--1 204.0022.3%-
Small Molecules--767.0014.2%-
Cell & Gene--602.0011.1%-
Corporate/Eliminations36.000.8%137.002.5% +280.56%
CHF in Million
Sales per region
2021
United States2 117.0040.3%
Switzerland656.0012.5%
Ireland399.007.6%
Rest of Europe218.004.2%
Japan206.003.9%
Belgium202.003.8%
Germany201.003.8%
United Kingdom170.003.2%
China143.002.7%
Sweden142.002.7%
Singapore139.002.6%
Denmark131.002.5%
France97.001.8%
Canada82.001.6%
South Korea79.001.5%
Netherlands76.001.4%
Brazil60.001.1%
Rest of Latin America47.000.9%
Spain44.000.8%
India40.000.8%
CHF in Million
Managers
Name Title Age Since
Pierre-Alain Ruffieux Chief Executive Officer 52 2020
Philippe Deecke Chief Financial Officer 49 2021
Stefan Stoffel Head-Small Molecules Exclusive Synthesis Operation 55 2007
Dirk Oehlers Investor Relations Officer - 2002
Paula McGeechan Gbl Head-Hygn & Prsrvtn Tech, Cons Prod Ingrdnts - -
Caroline Barth Chief Human Resources Officer 49 2020
Members of the board
Name Title Age Since
Albert Baehny Chairman 69 2020
Werner J. Bauer, Dr. Independent Director 71 2013
Barbara May Richmond Independent Director 61 2014
Juergen Steinemann Independent Director 63 2014
Christoph Mäder Independent Director 62 2016
Angelica Kohlmann, Dr. Independent Director 60 2018
Olivier Verscheure, Dr. Independent Director 49 2018
Dorothée Anna Deuring Independent Director 53 2020
Marion Helmes, Dr. Independent Director 55 2022
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 74,468,752 73,447,238 98.6% 279,623 0.4% 98.6%
Shareholders
NameEquities%
Artisan Partners LP 2,214,452 2.97%
BlackRock Investment Management (UK) Ltd. 2,133,806 2.87%
The Vanguard Group, Inc. 1,880,785 2.53%
Norges Bank Investment Management 1,778,256 2.39%
Fidelity Management & Research Co. LLC 1,491,820 2.00%
Capital Research & Management Co. (World Investors) 1,441,066 1.94%
Harris Associates LP 1,136,402 1.53%
Covéa Finance SAS 1,042,024 1.40%
WCM Investment Management LLC 1,030,566 1.38%
UBS Asset Management Switzerland AG 916,243 1.23%
Holdings
NameEquities%Valuation
LONZA GROUP AG (LONN) 185,680 0.25% 110,644,740 USD
AFFINIA THERAPEUTICS INC 4,990,478 8.63% 50 USD
Markets and indexes
- Primary listing
- SMI / STOXX Europe 600
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  LONN.S
- Datastream Code :  
Company contact information
Lonza Group AG
Münchensteinerstrasse 38
CH-4002 Basel, Basel-Stadt

Phone : +41 61 316 81 11
Fax :
web site : http://www.lonzagroup.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Lonza Group AG